AMANDA BLALOCK: Open Payments
NPI 1740681279 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$556 in 22 payments from 9 companies in 2025. Trend: 2023 $2,395 · 2024 $2,111 · 2025 $556
Food & beverage: $556
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 4 | $162 |
| Teva Pharmaceuticals USA, Inc. | 6 | $120 |
| Vanda Pharmaceuticals Inc. | 2 | $76 |
| Neurocrine BioSciences, Inc. | 3 | $61 |
| Lundbeck LLC | 3 | $44 |
| E.R. Squibb & Sons, L.L.C. | 1 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Alkermes, Inc. | 1 | $15 |
Products named: SPRAVATO, FANAPT, UZEDY, INGREZZA, AUSTEDO XR, INVEGA SUSTENNA, COBENFY, REXULTI.
Industry payments across TX — which companies pay providers there.
